NORWALK, Conn., Dec. 20, 2024 /PRNewswire/ -- Emeren Group Ltd ("Emeren" or the "Company") (www.emeren.com) (NYSE: SOL), a leading global solar project developer, owner, and operator, today announced the sale of its 2.8 MWdc solar project located in Maine to Altus Power, Inc. ("Altus Power") (NYSE: AMPS), the largest commercial scale provider of clean electric power. This transaction underscores Emeren's commitment to advancing clean energy solutions and its active role in supporting renewable energy goals ...

Toronto, Ontario--(Newsfile Corp. - December 11, 2024) - SOL Global Investments Corp. (CSE: SOL) (OTC Pink: SOLCF) (FSE: 9SB) ("SOL" or "the Company") is pleased to announce that it has successfully repaid $3.4 million of its outstanding debt to its senior lender, Braebeacon Holdings Inc., decreasing the loan balance to $10.2 million.This repayment aligns with SOL Global's broader financial objectives and reflects the Company's ongoing commitment to strengthening its financial position and reducing leverag ...

SOL Global Announces Closing of C$3.6 Million Brokered Private Placement of Units100% of Net Proceeds Will be Used for the Purchase of Additional Solana TokensDecember 03, 2024 9:02 AM EST | Source: SOL Global Investments Corp.Toronto, Ontario--(Newsfile Corp. - December 3, 2024) - SOL Global Investments Corp. (CSE: SOL) (OTC Pink: SOLCF) (FSE: 9SB) ("SOL Global" or the "Company") is pleased to announce that it has closed its previously announced brokered private placement. The Company sold 18 ...

NORWALK, Conn., Dec. 2, 2024 /PRNewswire/ -- Emeren Group Ltd ("Emeren" or the "Company") (www.emeren.com) (NYSE: SOL), a leading global solar project developer, owner, and operator, today announced the release of its 2023 Environmental, Social, and Governance (ESG) Report. The report highlights the company's achievements in advancing sustainability, fostering inclusivity, and maintaining robust governance, underpinned by a systematic and transparent approach aligned with the Global Reporting Initiative (GR ...

SOL-1 is the first registrational trial for AXPAXLI™ in wet AMD Topline clinical data from SOL-1 expected in Q4 2025 Active clinical trial sites enrolling patients directly into second registrational trial, SOL-R, while additional sites continue to be activated BEDFORD, Mass., Dec. 02, 2024 (GLOBE NEWSWIRE) -- Ocular Therapeutix, Inc. (NASDAQ: OCUL, "Ocular", the "Company"), a biopharmaceutical company committed to improving vision in the real world through the development and commercialization of innovativ ...

NORWALK, Conn., Nov. 21, 2024 /PRNewswire/ -- Emeren Group Ltd ("Emeren" or the "Company") (www.emeren.com) (NYSE: SOL), a leading global solar project developer, owner, and operator, today announced its participation in the following investor conferences: Janney's 2nd Annual Clean Energy Investment Symposium on December 4-5, 2024, in New Orleans, LA. BofA Securities 2024 Clean Energy Symposium on December 5-6, 2024, in New York, NY. The management team will present at a panel at 3:30 p.m. Eastern Time on D ...

NOT FOR DISTRIBUTION TO UNITED STATES NEWS WIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES TORONTO, Nov. 19, 2024 (GLOBE NEWSWIRE) -- SOL Global Investments Corp. (CSE: SOL; OTC Pink: SOLCF) (FSE: 9SB) (“SOL Global” or the “Company”) is pleased to announce that it has entered into an agreement with Canaccord Genuity Corp. (“Canaccord Genuity”) and Clarus Securities Inc. (“Clarus”, and together with Canaccord Genuity, the “Co-Lead Agents”), as co-lead agents and co-bookrunners, and on behalf of a syn ...

Exhibit 99.1 Nov. 14, 2024 Fellow Shareholders, In Q3 2024, our company executed on its bottom-line focus, achieving solid profitability despite softer-than-anticipated revenue resulting from delays in closing scheduled project sales. With $12.9 million in revenue, we achieved a gross profit of approximately $5.6 million (yielding a solid gross margin of 43.8%), $2.1 million in operating profit and $4.8 million in net income . Strong EBITDA of $8.5 million further reflects our commitment to sustainable prof ...

Emeren Group Ltd.'s (SOL) share price dropped 4.5% to reach $1.91 on Nov. 15, following its latest quarterly release. Emeren reported an income per American Depositary Share of nine cents for the third quarter of 2024, which came in line with the Zacks Consensus Estimate. The figure reflects an improvement from the year-ago quarter's loss of 17 cents per share. SOL's Revenues Emeren's net revenues of $12.9 million declined 7.2% from $13.9 million reported in the year-ago period. The year-over-year deteriora ...

SOL LISTED NYSE NYSE: SOL Q3 2024 Earnings Presentation November 14, 2024 Safe Harbor Statement 2 NYSE: SOL This presentation contains statements that constitute "forward-looking" statements within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended, and as defined in the U.S. Private Securities Litigation Reform Act of 1995. Whenever you read a statement that is not simply a statement of historical fact (such as when the C ...